A research “pipeline” is the process of creating, testing, and ultimately approving a new drug for use in humans. Huntington’s Disease Society of America funds researchers and doctors who are doing Huntington’s Disease (HD) research at different stages along the pipeline, and collaborates with industry partners to bring information about clinical trials to the public.
We Can Never Lose HOPE because there are many therapies in the pipeline. Genentech/Roche and Wave Life Science halted two (2) clinical trials, phase 3, this year that looked promising and that was a disappointing but we shouldn’t lose HOPE. Click here to see the other therapies being conducted around the world.
Basic research into what goes wrong in the brain in Huntington’s disease continues to provide insights into how the disease might be treated. As targets are identified, existing drugs and supplements known to address that target are reviewed and drug development efforts are instituted.